Vertex Pharmaceuticals Incorporated (BIT:1VRTX)

Italy flag Italy · Delayed Price · Currency is EUR
389.60
+13.65 (3.63%)
At close: Jan 21, 2026
-4.07%
Market Cap100.03B
Revenue (ttm)9.99B
Net Income (ttm)3.13B
Shares Outn/a
EPS (ttm)12.12
PE Ratio31.94
Forward PE22.63
Dividendn/a
Ex-Dividend Daten/a
Volume1
Average Volume6
Open378.00
Previous Close375.95
Day's Range378.00 - 378.00
52-Week Range316.00 - 482.10
Betan/a
RSI52.12
Earnings DateFeb 12, 2026

About Vertex Pharmaceuticals

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF with at least one F508del mutation for 2 years of age and older; ALYFTREK for the treatment for people with CF 6 years of age and older; SYMDEKO/SYMKEVI for treatment of patients with CF 6 years of age and older; ORKAMBI for CF patients 1 year or older; and KALYDECO for the treatment of patients with 1 month or older who have CF with ivacaftor. The com... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 1989
Employees 6,100
Stock Exchange Borsa Italiana
Ticker Symbol 1VRTX
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements